Are tumor-associated micro-angiogenesis and lymphangiogenesis considered as the novel prognostic factors for patients with Xp11.2 translocation renal cell carcinoma?

Table 2 Distribution characteristics of microvessels and lymphatic vessels in both Xp11.2 translocation RCC and ccRCC

Histological subtypes		Xp11.2 translocation RCC	ccRCC	P-value
Histological subtypes		Mean ± SD	Mean ± SD	P-value
Intra-tumor	MVD	157 ± 10^*	153 ± 12^*	0.723
	MVA	44,259 ± 8701^*	45,665 ± 10559^*	0.649
	LVD	1 ± 2^*	2 ± 2^*	0.692
	LVA	535 ± 563^*	481 ± 465^*	0.680
Peri-tumor	MVD	108 ± 10	110 ± 11	0.247
	MVA	34,975 ± 6131	37,009 ± 6841	0.362
	LVD	10 ± 3	8 ± 3	0.040
	LVA	3326 ± 1568	2556 ± 1120	0.029

Xp11.2 translocation RCC Xp11.2 translocation renal cell carcinoma, ccRCC Clear cell renal cell carcinoma, MVD Microvascular density, MVA Microvascular area, LVA Lymph vessel area, LVD Lymph vessel density, SD Standard deviation; ^*showed the difference of parameters between intra-tumor and peri-tumor, P < 0.05

ISSN: 1471-2407